Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 92 filers reported holding Y-MABS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,286,000 | -59.8% | 297,252 | -15.7% | 0.06% | -58.6% |
| Q1 2021 | $10,666,000 | -24.4% | 352,717 | +23.8% | 0.16% | -31.1% |
| Q4 2020 | $14,104,000 | +23.2% | 284,868 | -4.5% | 0.23% | -3.0% |
| Q3 2020 | $11,448,000 | -20.6% | 298,213 | -10.7% | 0.24% | -33.0% |
| Q2 2020 | $14,423,000 | +24.3% | 333,860 | -24.9% | 0.35% | -9.5% |
| Q1 2020 | $11,600,000 | -17.0% | 444,436 | -0.6% | 0.39% | +4.3% |
| Q4 2019 | $13,976,000 | +159.0% | 447,242 | +116.0% | 0.37% | +111.4% |
| Q3 2019 | $5,397,000 | +18.1% | 207,089 | +3.6% | 0.18% | +23.1% |
| Q2 2019 | $4,570,000 | – | 199,843 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 216,916 | $6,191,000 | 3.86% |
| Sofinnova Investments, Inc. | 2,194,278 | $62,625,000 | 3.71% |
| MPM BioImpact LLC | 452,970 | $12,928,000 | 2.00% |
| Soleus Capital Management, L.P. | 265,700 | $7,583,000 | 1.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 452,110 | $12,903,000 | 1.17% |
| ORACLE INVESTMENT MANAGEMENT INC | 315,642 | $9,008,000 | 1.12% |
| First Light Asset Management, LLC | 577,663 | $16,487,000 | 1.09% |
| Lombard Odier Asset Management (Switzerland) SA | 352,839 | $10,070,000 | 0.62% |
| Cormorant Asset Management, LP | 500,000 | $14,270,000 | 0.58% |
| Artal Group S.A. | 400,000 | $11,416,000 | 0.26% |